about
Overexpression of lipocalins and pro-inflammatory chemokines and altered methylation of PTGS2 and APC2 in oral squamous cell carcinomas induced in rats by 4-nitroquinoline-1-oxideMultiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeuticsBone cement augmentation procedures for spinal pathologic fractures by multiple myelomaCCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone diseaseThe inflammatory chemokine CCL5 and cancer progressionThe chemokine system and cancer.Therapeutic potential of CCR1 antagonists for multiple myeloma.Differential Expression of Chemokine Receptors and their Roles in Cancer Imaging.Vitamin D Impacts the Expression of Runx2 Target Genes and Modulates Inflammation, Oxidative Stress and Membrane Vesicle Biogenesis Gene Networks in 143B Osteosarcoma Cells.Identifying bias in CCR1 antagonists using radiolabelled binding, receptor internalization, β-arrestin translocation and chemotaxis assays.Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.Mesenchymal Stem Cells Support Survival and Proliferation of Primary Human Acute Myeloid Leukemia Cells through Heterogeneous Molecular MechanismsC-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.Comparative analysis of the surgical treatment results for multiple myeloma bone disease of the spine and the long bone/soft tissue.MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma.
P2860
Q28543174-63114C57-B120-4127-9347-2F21A14CEECEQ34038854-2D4264FB-13B2-4715-81FC-8FAD46732559Q34779509-2AFDEBB2-68EC-48FA-B375-A40A25234F8EQ36177928-D90DF4E7-6B36-41EA-B921-65DFAA1111E3Q37541911-7283E345-FEC4-46B6-A671-141769C23DD5Q37944479-A062B2A3-2EF0-488B-9927-CFEA36FD49BBQ37948866-06088D25-8262-4E9F-B40D-6FB4CA969550Q38015856-54BFD818-2683-421C-A7EC-9578EA90FAC7Q38712047-17776015-AC0B-413A-9D2A-12A4A28979DAQ38978556-4511C7AE-15E3-458B-82F8-45866B4E6FC0Q42158465-26F366ED-6DCA-44AE-B6DE-98CF1A27B242Q42262053-09CF2BB7-03D8-4EE1-9262-741C6A909F71Q49502927-15F504F2-38EF-4657-A62A-6CB51ABE1F30Q55311492-3087BF6D-CCC2-4267-B99B-33E8CAD58FCCQ55498024-E654EB46-CF09-4F4B-B92D-0534570CE90B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CCR1 as a target for multiple myeloma.
@en
CCR1 as a target for multiple myeloma.
@nl
type
label
CCR1 as a target for multiple myeloma.
@en
CCR1 as a target for multiple myeloma.
@nl
prefLabel
CCR1 as a target for multiple myeloma.
@en
CCR1 as a target for multiple myeloma.
@nl
P2860
P1476
CCR1 as a target for multiple myeloma.
@en
P2093
Sonia Vallet
P2860
P304
P356
10.1517/14728222.2011.586634
P407
P577
2011-05-24T00:00:00Z